Clinical trial
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
NCT02468024
Study timeline
Study start (actual)2015-07-01Date precision: month
Registry last updated2026-04-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-Small Cell Lung Cancerunresolved
Interventions
Lung SurgeryPROCEDURE
Radiation therapyRADIATION
Sponsors & collaborators
University of Texas Southwestern Medical Centerlead sponsor
Mapped research locations
ClevelandOhio, United States2PittsburghPennsylvania, United States2MilwaukeeWisconsin, United States2New YorkNew York, United States1BostonMassachusetts, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1TorontoOntario, Canada1SeattleWashington, United States1CincinnatiOhio, United States1ColumbusOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02468024 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.